IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $460 | -68.2% | 29,000 | -62.1% | 0.00% | -66.7% |
| Q2 2023 | $1,445 | +48.7% | 76,600 | -69.7% | 0.01% | +500.0% |
| Q1 2023 | $972 | +132.5% | 253,200 | +200.0% | 0.00% | -50.0% |
| Q4 2022 | $418 | -99.9% | 84,400 | -36.1% | 0.00% | -33.3% |
| Q3 2022 | $630,000 | +6.1% | 132,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $594,000 | -2.5% | 132,000 | +3.1% | 0.00% | +50.0% |
| Q1 2022 | $609,000 | -35.8% | 128,000 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $949,000 | +35.2% | 128,000 | +3.3% | 0.00% | 0.0% |
| Q3 2021 | $702,000 | -17.4% | 123,900 | -4.0% | 0.00% | 0.0% |
| Q2 2021 | $850,000 | +1228.1% | 129,000 | +435.3% | 0.00% | – |
| Q3 2016 | $64,000 | -16.9% | 24,100 | -3.6% | 0.00% | – |
| Q2 2016 | $77,000 | -63.8% | 25,000 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $213,000 | -37.2% | 25,000 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $339,000 | +46.8% | 25,000 | +3.7% | 0.00% | +100.0% |
| Q3 2015 | $231,000 | – | 24,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |